Professional Documents
Culture Documents
Varicella Zoster Virus
Varicella Zoster Virus
Johnsy Johnson
2009D004
Varicella Zoster Virus
Varicella (Chicken Pox)
•Acute, highly contagious viral disease with worldwide
distribution.
•Mostly a mild disorder in childhood.
•Tends to be more severe in adults.
•It may be fatal:
i. Neonates (baby or an infant).
ii. Immunocompromised person.
The Pathogen
Vaccine
•Oka strain of VZV
•A single dose of vaccine : *Seroconversion 95%
•Optimal age for Varicella vaccination is 12–24 months.
•In Immunocompromised persons, including patients with
advanced HIV infection
Contraindication : fear of disseminated vaccine-induced
disease
Vaccine safety :
Patients with leukemia(abnormal proliferation of
leucocytes) in remission or solid tumors before
chemotherapy.
Uremic patients waiting for transplantation.
•A killed Varicella vaccine has been studied in VZV-positive
bone marrow transplant patients where a multiple-dose
schedule has been used to
reduce the severity of zoster
•Postherpetic neuralgia
•Ocular involvement with facial zoster
•Meningoencephalitis
•Cutaneous dissemination
•Superinfection of skin lesions
•Hepatitis/pneumonitis
•Peripheral motor weakness/segmental myelitis
•Cranial nerve syndromes, particularly ophthalmic and facial
(Ramsay Hunt syndrome)
•Corneal ulceration
•Guillain-Barré syndrome
Thank You!!